Prediction of probability of pneumonectomy for lung cancer using Tc-99m MAA perfusion lung imaging

C. Y. Chen, C. H. Kao, N. Y. Hsu, C. L. Chen, C. P. Hsu, P. Y. Wang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Pulmonary perfusion scintigraphy with Tc-99m MAA was performed on 182 patients, on whom either pneumonectomy or lobectomy was performed, because of primary nonsmall-cell lung carcinoma. Among them, 76 underwent pneumonectomy, and 106 underwent lobectomy. The mean value of the perfusion fraction (PF) of the affected lung of the patients undergoing pneumonectomy was 32.3 ± 13.6% (range, 4%-50%) and was less than that of the patients undergoing lobectomy, 43.5 ± 4.5% (range, 27%-50%). The difference was statistically significant (t-test, t = 6.82; P <0.001). Among the 28 patients whose PF of the affected lung was equal to or less than 30%, 26 underwent pneumonectomy and only 2 had a lobectomy. Among the 154 patients whose PF of the affected lung was more than 30%, 50 underwent pneumonectomy and 104 had a lobectomy. These result suggest that '30%' can be a cutoff value (Yates correction X2 test, X2 = 33.09; P <0.001).

Original languageEnglish
Pages (from-to)1094-1097
Number of pages4
JournalClinical Nuclear Medicine
Volume19
Issue number12
Publication statusPublished - 1994
Externally publishedYes

Fingerprint

Technetium Tc 99m Aggregated Albumin
Perfusion Imaging
Pneumonectomy
Lung Neoplasms
Lung
Perfusion
Carcinoma

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Chen, C. Y., Kao, C. H., Hsu, N. Y., Chen, C. L., Hsu, C. P., & Wang, P. Y. (1994). Prediction of probability of pneumonectomy for lung cancer using Tc-99m MAA perfusion lung imaging. Clinical Nuclear Medicine, 19(12), 1094-1097.

Prediction of probability of pneumonectomy for lung cancer using Tc-99m MAA perfusion lung imaging. / Chen, C. Y.; Kao, C. H.; Hsu, N. Y.; Chen, C. L.; Hsu, C. P.; Wang, P. Y.

In: Clinical Nuclear Medicine, Vol. 19, No. 12, 1994, p. 1094-1097.

Research output: Contribution to journalArticle

Chen, CY, Kao, CH, Hsu, NY, Chen, CL, Hsu, CP & Wang, PY 1994, 'Prediction of probability of pneumonectomy for lung cancer using Tc-99m MAA perfusion lung imaging', Clinical Nuclear Medicine, vol. 19, no. 12, pp. 1094-1097.
Chen, C. Y. ; Kao, C. H. ; Hsu, N. Y. ; Chen, C. L. ; Hsu, C. P. ; Wang, P. Y. / Prediction of probability of pneumonectomy for lung cancer using Tc-99m MAA perfusion lung imaging. In: Clinical Nuclear Medicine. 1994 ; Vol. 19, No. 12. pp. 1094-1097.
@article{d27905318cbb47a7b832195b93c49d05,
title = "Prediction of probability of pneumonectomy for lung cancer using Tc-99m MAA perfusion lung imaging",
abstract = "Pulmonary perfusion scintigraphy with Tc-99m MAA was performed on 182 patients, on whom either pneumonectomy or lobectomy was performed, because of primary nonsmall-cell lung carcinoma. Among them, 76 underwent pneumonectomy, and 106 underwent lobectomy. The mean value of the perfusion fraction (PF) of the affected lung of the patients undergoing pneumonectomy was 32.3 ± 13.6{\%} (range, 4{\%}-50{\%}) and was less than that of the patients undergoing lobectomy, 43.5 ± 4.5{\%} (range, 27{\%}-50{\%}). The difference was statistically significant (t-test, t = 6.82; P <0.001). Among the 28 patients whose PF of the affected lung was equal to or less than 30{\%}, 26 underwent pneumonectomy and only 2 had a lobectomy. Among the 154 patients whose PF of the affected lung was more than 30{\%}, 50 underwent pneumonectomy and 104 had a lobectomy. These result suggest that '30{\%}' can be a cutoff value (Yates correction X2 test, X2 = 33.09; P <0.001).",
author = "Chen, {C. Y.} and Kao, {C. H.} and Hsu, {N. Y.} and Chen, {C. L.} and Hsu, {C. P.} and Wang, {P. Y.}",
year = "1994",
language = "English",
volume = "19",
pages = "1094--1097",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Prediction of probability of pneumonectomy for lung cancer using Tc-99m MAA perfusion lung imaging

AU - Chen, C. Y.

AU - Kao, C. H.

AU - Hsu, N. Y.

AU - Chen, C. L.

AU - Hsu, C. P.

AU - Wang, P. Y.

PY - 1994

Y1 - 1994

N2 - Pulmonary perfusion scintigraphy with Tc-99m MAA was performed on 182 patients, on whom either pneumonectomy or lobectomy was performed, because of primary nonsmall-cell lung carcinoma. Among them, 76 underwent pneumonectomy, and 106 underwent lobectomy. The mean value of the perfusion fraction (PF) of the affected lung of the patients undergoing pneumonectomy was 32.3 ± 13.6% (range, 4%-50%) and was less than that of the patients undergoing lobectomy, 43.5 ± 4.5% (range, 27%-50%). The difference was statistically significant (t-test, t = 6.82; P <0.001). Among the 28 patients whose PF of the affected lung was equal to or less than 30%, 26 underwent pneumonectomy and only 2 had a lobectomy. Among the 154 patients whose PF of the affected lung was more than 30%, 50 underwent pneumonectomy and 104 had a lobectomy. These result suggest that '30%' can be a cutoff value (Yates correction X2 test, X2 = 33.09; P <0.001).

AB - Pulmonary perfusion scintigraphy with Tc-99m MAA was performed on 182 patients, on whom either pneumonectomy or lobectomy was performed, because of primary nonsmall-cell lung carcinoma. Among them, 76 underwent pneumonectomy, and 106 underwent lobectomy. The mean value of the perfusion fraction (PF) of the affected lung of the patients undergoing pneumonectomy was 32.3 ± 13.6% (range, 4%-50%) and was less than that of the patients undergoing lobectomy, 43.5 ± 4.5% (range, 27%-50%). The difference was statistically significant (t-test, t = 6.82; P <0.001). Among the 28 patients whose PF of the affected lung was equal to or less than 30%, 26 underwent pneumonectomy and only 2 had a lobectomy. Among the 154 patients whose PF of the affected lung was more than 30%, 50 underwent pneumonectomy and 104 had a lobectomy. These result suggest that '30%' can be a cutoff value (Yates correction X2 test, X2 = 33.09; P <0.001).

UR - http://www.scopus.com/inward/record.url?scp=0028052230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028052230&partnerID=8YFLogxK

M3 - Article

C2 - 7874810

AN - SCOPUS:0028052230

VL - 19

SP - 1094

EP - 1097

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 12

ER -